In diet-induced obese mice (16 weeks HFD), subcutaneous 5-Amino-1MQ treatment for 11 days (20 mg/kg/injection, three injections daily) produced significantly reduced body weights, white adipose tissue masses, and adipocyte cell sizes compared to vehicle controls
GHK-Cu was part of that broader discussion, and the FDA later updated its bulk drug substance list
Injectable delivery produces measurable plasma levels and allows the peptide to reach tissues that topical application cannot including deeper wound beds, joint spaces in preclinical models, and scalp follicles below the penetration limit of topical creams
Kaushansky K, Lichtman MA, Prchal J, et al
Cannot redeclare control with same name "grid_3_cta_background_hover_attachment"